¿À´ÃÀº
·ù¸¶Æ¼½º Ŭ¸®´Ð
   ÀÇ·áÁø
      Çз¤ý°æ·Â
      ¼ö»ó°æ·Â¤ýÇÐȸȰµ¿
      ÁÖ¿ä³í¹®
      ½Å¹®°ÔÀç
   º´¿ø¾È³»
      º´¿ø¾àµµ¤ýÁÖÂ÷¾È³»
      ±³Åë¾È³»
 
 
   < ÀÇ·áÁø : ¹ÚÀçÈ£ ¿øÀå ÇÁ·ÎÇÊ>


ÁÖ¿ä³í¹®

        1. The diagnosis, pathophysiology, and treatment of gout.
            Current Opinion in Orthopedics 1995;6(5):20-25.

        2. Steroid sparing effect of methotrexate  in relapsing polychondritis.
            The Journal of Rheumatology 1996;23:937-938.
  
          Cecil's Textbook of Medicine Á¦21ÆÇ¿¡ Âü°í¹®ÇåÀ¸·Î Àοë, µîÀçµÊ

         3. The clinical significance of cytoplasmic inclusions(CPI)  in synovial fluid             examination.
            Journal of Korean Medical Science 1996;11(4):326-331.

         4. Clinical assessment of the 1987 American College of   Rheumatology criteria             for rheumatoid arthritis.
            Scandinavian Journal of Rheumatology 1996;25:277-281.

         5. Effect of a nonsteroidal antiinflammatory drug  on synovial fluid in            osteoarthritis.
            The Journal of Rheumatology 1996;23:1774-1777.

         6. BucillamineÀÇ Ç×·ù¸¶Æ¼½º ÀÛ¿ëÁß ÀÓÆı¸¿¡ ´ëÇÑ È¿°ú.
            ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö 1996;3(2):172-178.

         7. Decreased tumour necrosis factor-beta production in  TNFB*2 homozygote
             : an important predisposing factor of lupus nephritis in Koreans.
              Lupus 1997;6:603-609.

         8. Bronchiolitis obliterans organizing pneumonia as an initial  manifestation in
            patients with systemic lupus erythematosus.
            The Journal of Rheumatology 1997;24:2254-2257.  

         9. µ¿¹°¸ðµ¨¿¡¼­ÀÇ ±Þ¼º Åëdz¹ßÀÛ À¯¹ßÀÎÀÚ¿Í Á¶Á÷ÇÐÀû º¯È­.
            ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö, Vol.5, No.2(1998), pp. 169-176

         10. The clinical significance of IgG antibodies to native  human type II collagen              in patients with rheumatoid arthritis.
             ´ëÇѸ鿪ÇÐȸÁö 1998, Á¦ 20±Ç Á¦ 4È£, pp. 451-457.

         11. Clinical analysis of Behcet disease : arthritic manifestation  in Behcet
             disease may present as seronegative rheumatoid arthritis or palindromic              rheumatism.
             Korean J Intern Med, Vol.14, No.1(1999), pp. 66-72

         12. °áÇÙ±Õ Rhamnose »ýÇÕ¼ºÈ¿¼Ò RfbCÀÇ °ú´Ù¹ßÇö - (¹Ú»çÇÐÀ§³í¹®)   

         13. ·ù¸¶Æ¼½º¼º °üÀý¿°¿¡¼­ Àü½Å °ñ ½ºÄµÀÇ À¯¿ë¼º.
             °è¸íÀÇ´ë³í¹®Áý Á¦ 18±Ç 1È£, pp. 134-145

        14. Æ󵿸ưíÇ÷¾Ð, ¹Ì¼¼Ç÷°üº´¼º ¿ëÇ÷¼º ºóÇ÷ ¹× ÇǺα«»ç¸¦ µ¿¹ÝÇÑ Àü½Å¼º È«¹Ý¼º
             ·çǪ½º.
             ´ëÇѳ»°úÇÐȸÁö, Vol.57, S¥±(1999), pp. S202

        15. Àç»ýºÒ·®¼º ºóÇ÷À» µ¿¹ÝÇÑ Àü½Å¼º È«¹Ý¼º ·çǪ½º.
             ´ëÇѳ»°úÇÐȸÁö, Vol.57, S¥±(1999), pp. S171

        16. ¿ì½É¹æ Ç÷Àü, Æóµ¿¸Æ »öÀü°ú ÇϺδëÁ¤¸Æ Æó¼â¸¦ º¸ÀÎ Behcet¾¾ º´.
             ´ëÇѳ»°úÇÐȸÁö, Vol.57, S¥±(1999), pp. S185

        17. Adult respiratory distress syndrome in systemic lupus erythematosus :              causes and   prognostic factors: a single center, retrospective study.              Lupus 1999;8:552-557

        18. Enhanced T Cell Proliferative Response to Type¥± Collagen and Synthetic              Peptide C¥± (255-274) in patients with Rheumatoid Arthritis.
             Arthritis & Rheumatism, Vol. 42, No.10(1999), pp. 2085-2093

        19. Àü½Å¼º È«¹Ý¼º ·çǪ½º ȯÀÚ¿¡¼­ ¹ß»ýÇÑ Àç¹ß¼º ´Ù¹ß¼º ¿¬°ñ¿°.
             °è¸íÀÇ´ëÀâÁö 1999³â Á¦ 18±Ç 4È£ pp. 516-522.

        20. Cryptococcal Tenosynovitis in the Setting of Disseminated Cryptococcosis.
             The Journal of Rheumatology 2000;27:282-283.  

        21. Àü½Å¼º È«¹Ý¼º ·çǪ½º ȯÀÚ¿¡¼­ ¹ß»ýÇÑ Àü½Å ÇÇÇÏÁ¶Á÷ ¼®È¸È­.
             ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö 2000³â Á¦ 7±Ç Á¦ 1È£(3¿ù) pp. 77-82.

        22. IgG antibodies to type II collagen reflect inflammatory activity in patients with              rheumatoid arthritis.
             The Journal of Rheumatology 2000;27:575-81.

        23. ¿ìȸÀû À§°øÀå¹®ÇÕ¼ú ÈÄ¿¡ ¹ß»ýÇÑ °üÀý¿°-ÇǺο° ÁõÈıº.
              ´ëÇѳ»°úÇÐȸÁö 2000;59(5):583-586.


 


All contents ¨Ï Copyright 1999-2011 JHPark All rights reserved